Revenue
attach_money14M USD
-
XLOXilio Therapeutics, Inc.$ --
Xilio Therapeutics, Inc.
XLO
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
analyticsEarnings Summary
FY2025 Q4Updated: 12/31/2025
Operating Income
trending_up-12M USD
-
Net Income
verified45M USD
-
EPS
paid4.21$
-
Revenue
$13.7M
BEAT
$4.4M
$2.9M
$8.2M
$8.1M
$18.6M
$19.1M
$10.9M
$13.7M
$42.1M
$43.8M
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-
Net Income
$45.4M
BEAT
$-27.8M
$-13.3M
$-11.4M
$-15.8M
$-4.6M
$-16.3M
$-10.1M
$45.4M
$-53.8M
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-
Surprise History
ActualEstimate
FY2025BEAT